LOCUS AK307572 1465 bp mRNA linear HTC 12-JAN-2008 DEFINITION Homo sapiens cDNA, FLJ97520. ACCESSION AK307572 VERSION AK307572.1 KEYWORDS HTC; HTC_FLI; oligo capping. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 1465) AUTHORS Isogai,T. and Yamamoto,J. TITLE Direct Submission JOURNAL Submitted (11-JAN-2008) to the DDBJ/EMBL/GenBank databases. Contact:Takao Isogai Reverse Proteomics Research Institute; 1-9-11 Kaji-cho, Chiyoda-ku, Tokyo 101-0044, Japan E-mail :flj-cdna@nifty.com REFERENCE 2 AUTHORS Wakamatsu,A., Yamamoto,J., Kimura,K., Ishii,S., Watanabe,K., Sugiyama,A., Murakawa,K., Kaida,T., Tsuchiya,K., Fukuzumi,Y., Kumagai,A., Oishi,Y., Yamamoto,S., Ono,Y., Komori,Y., Yamazaki,M., Kisu,Y., Nishikawa,T., Sugano,S., Nomura,N. and Isogai,T. TITLE NEDO human cDNA sequencing project JOURNAL Unpublished (2008) COMMENT Human cDNA sequencing project focused on splicing variants of mRNA in NEDO functional analysis of protein and research application project supported by Ministry of Economy, Trade and Industry, Japan; cDNA selection for complete cds sequencing: Reverse Proteomics Research Institute (REPRORI), Hitachi, Ltd., Japan (Hitachi) and Japan Biological Informatics Consortium, Japan (JBIC); cDNA complete cds sequencing: JBIC; cDNA library construction: Helix Research Institute supported by Japan Key Technology Center, Japan (HRI); cDNA 5'- & 3'-end sequencing: Research Association for Biotechnology, Japan, Biotechnology Center, National Institute of Technology and Evaluation, Japan and HRI; cDNA mapping to human genome: Central Research Laboratory, Hitachi; evaluation and annotation: REPRORI. FEATURES Location/Qualifiers source 1..1465 /cell_line="NT2" /cell_type="teratocarcinoma" /clone="NT2RI2013683" /clone_lib="NT2RI2" /db_xref="H-InvDB:HIT000426438" /db_xref="taxon:9606" /mol_type="mRNA" /note="cloning vector: pME18SFL3" /note="mRNA from NT2 neuronal precursor cells treated 2-weeks mitotic inhibitor after 5-weeks retinoic acid (RA) induction." /note="majorly NT2 neuron" /organism="Homo sapiens" BASE COUNT 249 a 423 c 436 g 357 t ORIGIN 1 atatcgctgc ccggagccag cggggatggg agctgcggct tggttttgtg ctccttgggg 61 agcttcgggc ggaggggctg gggaccctga cgtcccggat cgtggagatg gtgggcagtg 121 gtggtgctgg ctgcgttccc ctccctaggg gcaggtgggg agactcccga agcccctccg 181 gagtcatgga cccagctatg gttcttccga tttgtggtga atgctgctgg ctatgccagc 241 tttatggtac ctggctacct cctggtgcag tacttcaggc ggaagaacta cctggagacc 301 ggtaggggcc tctgctttcc cctggtgaaa gcttgtgtgt ttggcaatga gcccaaggcc 361 tctgatgagg ttcccctggc gccccgaaca gaggcggcag agaccacccc gatgtggcag 421 gccctgaagc tgctcttctg tgccacaggg ctccaggtgt cttatctgac ttggggtgtg 481 ctgcaggaaa gagtgatgat ccgcagctat ggggccacag ccacatcacc gggtgagcgc 541 tttacggact cgcagttcct ggtgctaatg aaccgagtgc tggcactgat tgtggctggc 601 ctctcctgtg ttctctgcaa gcagccccgg catggggcac ccatgtaccg gtactccttt 661 gccagcctgt ccaatgtgct tagcagctgg tgccaatacg aagctcttaa gttcgtcagc 721 ttccccaccc aggtgctggc caaggcctct aaggtgatcc ctgtcatgct gatgggaaag 781 cttgtgtctc ggcgcagcta cgaacactgg gagtacctga cagccaccct catctccatt 841 ggggtcagca tgtttctgct atccagcgga ccagagcccc gcagctcccc agccaccaca 901 ctctcaggcc tcatcttact ggcaggttat attgcttttg acagcttcac ctcaaactgg 961 caggatgccc tgtttgccta taagatgtca tcggtgcaga tgatgtttgg ggtcaatttc 1021 ttctcctgcc tcttcacagt gggctcactg ctagaacagg gggccctact ggagggaacc 1081 cgcttcatgg ggcgacacag tgagtttgct gcccatgccc tgctactctc catctgctcc 1141 gcatgtggcc agctcttcat cttttacacc attgggcagt ttggggctgc cgtcttcacc 1201 atcatcatga ccctccgcca ggcctttgcc atccttcttt cctgccttct ctatggccac 1261 actgtcactg tggtgggagg gctgggggtg gctgtggtct ttgctgccct cctgctcaga 1321 gtctacgcgc ggggccgtct aaagcaacgg ggaaagaagg ctgtgcctgt tgagtctcct 1381 gtgcagaagg tttgagggtg gaaagggcct gaggggtgaa gtgaaatagg accctcccac 1441 catccccttc tgctgtaacc tctga //